(Q67994287)

English

In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa

scientific article published on 01 February 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

M Díez Enciso

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 February 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

90-92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1907544%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

https://scigraph.springernature.com/pub.10.1007/bf01964415

0 references

Beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of fluoroquinolones with other antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic combinations of antibiotics in gram-negative bacillary infections.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive evaluation of ciprofloxacin in combination with beta-lactam antibiotics against Enterobacteriaceae and Pseudomonas aeruginosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1907544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67994287&oldid=2152704059"